We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
Consensus vs. actual, and revenue trend
Consensus PT $2.46 · 7 analysts
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
Stored first · Google News · Yahoo Finance (English)
Definitive Healthcare (DH) CFO has shares withheld to cover RSU tax bill - Stock Titan
Definitive Healthcare (DH) CFO has shares withheld to cover RSU tax bill Stock Titan
Definitive Healthcare (DH) CEO sees 66,050 shares withheld for taxes - Stock Titan
Definitive Healthcare (DH) CEO sees 66,050 shares withheld for taxes Stock Titan
Innoviz Technologies Among 3 Compelling Penny Stocks To Consider
BTIG Maintains Definitive Healthcare(DH.US) With Hold Rating - 富途牛牛
BTIG Maintains Definitive Healthcare(DH.US) With Hold Rating 富途牛牛
Definitive Healthcare advances data platform and integrations to deliver smarter healthcare insights
Can Definitive Healthcare Corp. (DH) Maintain Stability After Revised Price Target From Baird?
| Quarter | Date | Time | EPS est. | EPS actual | Surprise | Rev. est. | Rev. actual | Status |
|---|---|---|---|---|---|---|---|---|
| — | 2026. 08. 06. | After market close (AMC) | $0.04 | — | — | $55.56M | — | Scheduled |
| FY2026 Q1 | 2025. 03. 31. | Time TBD | — | $-0.95 | — | — | $59.19M | Reported |
| FY2025 Q3 | 2024. 09. 30. | Time TBD | — | $-3.02 | — | — | $189.91M | Reported |
| FY2025 Q2 | 2024. 06. 30. | Time TBD | — | $-1.9 | — | — | $127.22M | Reported |
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2026. 03. 30. | Barclays | — | Maintain | Underweight → Underweight | — | Barclays: Underweight |
| 2026. 02. 28. | Canaccord Genuity | — | Maintain | Hold → Hold | — | Canaccord Genuity: Hold |
| 2026. 02. 28. | Stephens & Co. | — | Maintain | Equal-Weight → Equal-Weight | — | Stephens & Co.: Equal-Weight |
| 2025. 12. 10. | Barclays | — | Maintain | Underweight → Underweight | — | Barclays: Underweight |
| 2025. 11. 11. | Canaccord Genuity | — | Maintain | Hold → Hold | — | Canaccord Genuity: Hold |
| 2025. 08. 08. | Stifel | — | Maintain | Buy → Buy | — | Stifel: Buy |
Price data
| # | Institution | Mandate | Shares | Value | Weight | Change | Position |
|---|---|---|---|---|---|---|---|
| 1 | TWO SIGMA INVESTMENTS, LP | TWO SIGMA INVESTMENTS, LP | 137,824 | $395.56M | 0.00% | — | New position |
| 2 | TWO SIGMA INVESTMENTS, LP | TWO SIGMA INVESTMENTS, LP | 233,581 | $287.31M | 0.00% | — | New position |
| 3 | Point72 Asset Management, L.P. | Point72 Asset Management, L.P. | 61,149 | $175.5M | 0.00% | — | New position |
| 4 | Point72 Asset Management, L.P. | Point72 Asset Management, L.P. | 21,709 | $26.7M | 0.00% | — | New position |